Sionna Therapeutics (NASDAQ:SION), a clinical-stage biopharma focused on developing cystic fibrosis therapies, opened well above its initial public offering price on Friday in its first trading ...

Titan America, a subsidiary of Titan Cement International SA, commenced its initial public offering (IPO) today, with shares opening at $16.20, exceeding the IPO price of $16.00 per share. Shares ...